Higher preoperative serum levels of <scp>PD</scp>‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to <scp>VEGF</scp>‐targeted therapy and unfavorable prognosis of renal cell carcinomaTakehiko Fukuda, Ken‐Ichiro Yoshida|Cancer Medicine|2016Cited by 52
Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survivalTakao Kamai, Ken‐Ichiro Yoshida|Cancer Immunology Immunotherapy|2021Cited by 39
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinomaNobutaka Furuya, Ken‐Ichiro Yoshida|Cancer Immunology Immunotherapy|2011Cited by 18
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte densityAkinori Nukui, Ken‐Ichiro Yoshida|Cancer Immunology Immunotherapy|2020Cited by 16
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case reportTakao Kamai, Ken‐Ichiro Yoshida|OncoTargets and Therapy|2014Cited by 8